Vaccine-Makers Get Richer, Top Execs Pocket Millions

Moderna, the pharmaceutical company leading the COVID-19 vaccine race, has achieved tremendous success. It received $483 million in tax dollars to fund the testing and development of the vaccine, its stock price skyrocketed, and its top executives cashed out millions of dollars worth in shares.

Financial success aside, how’s the development of the vaccine going? As predicted, not very well. According to news reports, Moderna is fighting to lower the bar to prove the vaccine works, feuding with outside experts on how to run the process, delaying to submit protocols, as well as pushing back the start of its phase 3 trial.

But with the public’s support and strong belief that “life cannot go back to normal without a vaccine”, as well as government funding, companies like Moderna can continue to achieve great financial success even without having contributed anything to humanity.

So, unless you own stocks in these biotechs, you should stop worrying about vaccines and focus more on what you can do today to improve your health and boost your natural defences against all viruses. That, at least, is in your hands – and you will be all the richer for it.

Marc Jaoudé
Markito Fitness & Nutrition

1. Taylor, M. (2020, July 07). Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials. Retrieved July 08, 2020, from https://www.reuters.com/article/us-health-coronavirus-moderna-exclusive/exclusive-moderna-spars-with-us-scientists-over-covid-19-vaccine-trials-idUSKBN2481EU

Leave a Reply